This analysis covers Canopy's go-to-market strategy for US community oncology practices, focusing on enterprise AI for workflow automation, ePROs, and chronic care management. Segments are chosen based on practice size, regulatory pressure from CMS, and the availability of public data from CMS, ASCO, and state health registries.
Segments reflect varying pain points: large multi-site practices face administrative burden and revenue leakage from missed CCM/RTM billing, while smaller practices struggle with staff burnout and patient retention — all addressable with Canopy's platform.
CMS requires oncology practices to report electronic patient-reported outcomes (ePROs) under the Merit-based Incentive Payment System (MIPS). Failure to meet thresholds can reduce Medicare reimbursement by up to 9% per year. For a practice with $5M in annual Medicare revenue, that's a $450K loss annually (source: CMS QPP 2024 final rule).
Practices that do not enroll patients in Chronic Care Management (CCM, CPT 99490) or Remote Therapeutic Monitoring (RTM, CPT 98975) miss $50–$100 per patient per month in reimbursable services. With an average panel of 500 eligible patients, that's $300K–$600K in annual revenue left on the table (source: CMS Medicare Physician Fee Schedule 2024).
| # | Segment | TAM | Pain | Conversion | Score |
|---|---|---|---|---|---|
| 1 | High-Value Oncology Practices with Medicare CCM/RTM Gap NAICS 62111 · US · ~2,100 companies | ~2,100 | 0.90 | 15% | 88 / 100 |
| 2 | Community Oncology Practices in OCM/EOM Participating Networks NAICS 62111 · US · ~1,200 companies | ~1,200 | 0.85 | 12% | 82 / 100 |
| 3 | Rural Oncology Practices with High Medicare FFS Dependence NAICS 62111 · US · ~800 companies | ~800 | 0.80 | 10% | 78 / 100 |
| 4 | Independent Hematology-Oncology Groups with Low EHR Integration NAICS 62111 · US · ~600 companies | ~600 | 0.75 | 8% | 74 / 100 |
| 5 | Cancer Centers in Medicare Shared Savings Program ACOs NAICS 62111 · US · ~400 companies | ~400 | 0.70 | 6% | 71 / 100 |
The pain. Mid-sized oncology practices (5–10 physicians) are leaving $500K–$1.2M annually in unreimbursed Chronic Care Management (CCM) and Remote Therapeutic Monitoring (RTM) revenue due to manual workflows and lack of integrated ePRO tools. Without AI triage, symptom burden escalates, triggering avoidable ER visits that degrade Medicare Quality Payment Program (QPP) scores and future reimbursement rates.
How to identify them. Use the CMS Physician Compare database (medicare.gov) filtered by specialty 'Medical Oncology' and group size 5–10 providers. Cross-reference with the Medicare Data on Provider Practice and Specialty (MD-PPAS) to identify practices with high Medicare FFS volume and low CCM billing codes (99490, 99439) in the last 12 months.
Why they convert. The shift to value-based care under the Oncology Care Model (OCM) and its successor, Enhancing Oncology Model (EOM), directly penalizes practices without real-time symptom monitoring and triage. Administrators will act to avoid QPP payment adjustments that can reduce Medicare revenue by up to 9% in 2025.
The pain. Practices in the Enhancing Oncology Model (EOM) must report patient-reported outcomes (PROs) monthly or face payment reductions, yet most rely on paper forms or disjointed patient portals. This creates data gaps that lead to missed quality benchmarks and up to 20% lower shared savings payouts.
How to identify them. Download the CMS EOM participant list (cms.gov) and the OCM historical participant list from the CMS Innovation Center. Filter for community-based practices (not hospital-owned) with 3–15 providers that show low ePRO adoption based on publicly available patient satisfaction scores from CMS Hospital Compare (for affiliated hospitals).
Why they convert. The EOM mandates monthly symptom tracking with PRO tools starting 2024, and non-compliance triggers automatic payment cuts. Practices that adopt Canopy can turn this regulatory burden into a revenue stream by meeting quality thresholds for performance-based payments.
The pain. Rural oncology practices (2–5 physicians) face 35% higher ER utilization due to lack of remote symptom monitoring, driving up costs and triggering penalties under the Medicare Shared Savings Program (MSSP). They also miss CCM/RTM billing opportunities because manual workflows cannot scale across dispersed patient populations.
How to identify them. Use the Health Resources and Services Administration (HRSA) Data Warehouse to find rural health clinics and critical access hospitals with oncology services. Then cross-reference with the CMS Medicare FFS claims database (via MD-PPAS) to identify practices with >60% Medicare patient mix and low telehealth utilization codes (G0425–G0427).
Why they convert. The Medicare Telehealth Expansion Act of 2023 permanently waived originating site restrictions for CCM and RTM, making virtual triage immediately billable. Rural practices that fail to implement ePRO and AI triage will lose competitive advantage as neighboring hospitals expand virtual oncology services.
The pain. Independent hematology-oncology groups (4–8 physicians) using legacy EHRs like Allscripts or eClinicalWorks lack native ePRO modules, forcing nurses to manually call patients for symptom checks—wasting 12–20 hours per week. This inefficiency leads to delayed interventions and higher hospital readmission rates, which are publicly reported on the Hospital Readmissions Reduction Program.
How to identify them. Query the ONC Certified Health IT Product List (CHPL) (healthit.gov) for practices using non-integrated EHRs (e.g., Allscripts TouchWorks, eClinicalWorks) that lack certified ePRO modules. Then use the American Medical Association (AMA) Physician Masterfile to filter for hematology-oncology specialists in private practice groups with <50 providers.
Why they convert. The 2024 CMS Interoperability and Prior Authorization Rule requires EHRs to support patient-generated health data (PGHD) exchange, but most legacy systems cannot comply. Canopy fills this gap with a plug-and-play ePRO layer that avoids costly EHR replacement while unlocking RTM billing codes (98977, 98980).
The pain. Community cancer centers (5–15 physicians) participating in MSSP ACOs face shared losses if oncology patients have high ER visit rates, yet they lack AI triage to proactively manage symptoms at home. Without ePRO integration, they cannot attribute cost savings to their oncology department, risking ACO dissolution and loss of shared savings bonuses.
How to identify them. Access the CMS MSSP ACO participant list (cms.gov) and cross-reference with the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) sites. Filter for ACOs with >20% oncology patient panels and low performance on the CAHPS Clinician & Group Survey for cancer care coordination.
Why they convert. The MSSP's 2025 rule increases the minimum savings rate to 3%, making every avoidable ER visit a direct hit to ACO bonuses. Canopy's AI triage reduces ER utilization by 25–40% in published studies, directly improving ACO financial performance and justifying the investment.
| Database | Country | Reliability | What it reveals | Used in |
|---|---|---|---|---|
| CMS Enhancing Oncology Model (EOM) Participant List | US | HIGH | Lists oncology practices participating in the EOM, including practice name, NPI, TIN, address, and practice size. | Play 1 |
| ONC Certified Health IT Product List (CHPL) | US | HIGH | Certified EHR modules and health IT products used by practices, including ePRO and AI triage capabilities. | Play 1 |
| CMS Medicare Fee-for-Service Claims (MD-PPAS) | US | HIGH | Medicare Part B claims data including CCM/RTM billing codes (e.g., 99490, 99491, 99453, 99454). | Play 1 |
| CMS Hospital Compare | US | HIGH | Hospital quality measures and patient experience scores. | Play 1 |
| CMS Medicare Shared Savings Program (MSSP) ACO Participant List | US | HIGH | ACO participants including practices that may benefit from ePRO for population health. | Play 1 |
| HRSA Data Warehouse | US | HIGH | Health center locations and service areas for community oncology practices. | Play 1 |
| AMA Physician Masterfile | US | HIGH | Physician demographics, specialty, and practice location. | Play 1 |
| CMS Physician Compare | US | HIGH | Physician quality and patient experience data. | Play 1 |
| Medicare Data on Provider Practice and Specialty (MD-PPAS) | US | HIGH | Provider practice patterns and specialty-level data. | Play 1 |
| NCI Community Oncology Research Program (NCORP) Site List | US | HIGH | Community oncology research sites that may need ePRO for clinical trials. | Play 1 |
| CMS Quality Payment Program (QPP) Participation Data | US | HIGH | MIPS participation status, scores, and payment adjustments for practices. | Play 1 |
| National Plan and Provider Enumeration System (NPPES) | US | HIGH | NPI numbers, practice addresses, and taxonomy codes. | Play 1 |
| FDA Adverse Event Reporting System (FAERS) | US | MEDIUM | Adverse event reports that may indicate need for better symptom monitoring. | Play 1 |
| ClinicalTrials.gov | US | HIGH | Clinical trials at the practice that could benefit from ePRO integration. | Play 1 |
| Centers for Medicare & Medicaid Services (CMS) Open Payments Database | US | HIGH | Financial relationships between physicians and industry, including health IT vendors. | Play 1 |
| US Census Bureau County Business Patterns | US | HIGH | Number of oncology practices by geography and employee size. | Play 1 |